Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Precision oncology: Computational methods for multi-omics data integration to improve drug response prediction
1Department of Health Sciences, Northeastern University - Boston Campus, Boston, MA, USA.
Abstract:
Cancer heterogeneity presents a major obstacle to effective drug treatment, emphasizing the need for personalized approaches that can accurately predict drug responses. Advances in high-throughput technologies have driven precision medicine initiatives toward integrating multi-omics data, enabling a more comprehensive understanding of tumor biology. However, integration of diverse omics layers poses challenges for computational modeling, as many traditional machine learning (ML) and statistical methods are not designed to capture complex, high-dimensional and multimodal data. This review examines the studies that integrate multi-omics datasets, aiming to enhance drug response prediction (DRP). Specifically, it outlines the most used omics types and computational approaches - classical ML models, as well as advanced deep learning and multimodal integration frameworks for improving DRP, detailing key methodologies and evaluation metrics, such as area under the dose-response curve, F1 score and mean square error, which assess model performance. By summarizing the integrated omics data, computational methods and challenges encountered, this review provides an in-depth overview of the existing landscape of precision medicine and future directions for advancing drug-response prediction.
Insights
Integrating multi-omics data improves cancer drug response prediction (DRP) for personalized medicine. This review explores computational methods and challenges in using diverse omics data to predict treatment effectiveness.
Area of Science:
- Computational biology
- Genomics
- Precision medicine
Background:
- Cancer heterogeneity complicates drug treatment, necessitating personalized approaches.
- Multi-omics data integration advances precision medicine by enhancing tumor biology understanding.
- Integrating diverse omics data presents computational challenges for traditional methods.
Purpose of the Study:
- To review studies integrating multi-omics datasets for improved drug response prediction (DRP).
- To outline common omics types and computational approaches for DRP.
- To summarize challenges and future directions in multi-omics DRP.
Main Methods:
- Review of studies integrating multi-omics data for DRP.
- Categorization of omics types (e.g., genomics, transcriptomics).
- Analysis of computational approaches: classical machine learning (ML), deep learning, and multimodal integration frameworks.
Main Results:
- Identified key omics types and computational methods used in DRP.
- Detailed methodologies and evaluation metrics (e.g., AUC, F1 score, MSE).
- Summarized challenges in integrating high-dimensional, multimodal data.
Conclusions:
- Multi-omics data integration is crucial for advancing DRP in precision medicine.
- Advanced computational models are needed to handle complex omics data.
- Further research is required to overcome integration challenges and improve predictive accuracy.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Genomics
Pharmacogenomics: Identification of New Drug Targets
Analysis of Population Pharmacokinetic Data